AAN 2017

Burden of Multiple Sclerosis Relapses Is Underappreciated, Study Says

The burden of moderate-to-severe relapses in multiple sclerosis (MS) patients is underappreciated, according to a study sponsored by the pharmaceutical companyĀ Mallinckrodt. Researchers discussed the findings at the American Academy of Neurology’s 69th annual meeting in Boston, April 22-28. The title of the presentation was ā€œThe Economic Burden Of…